NS
DNLI icon

NBC Securities’s Denali Therapeutics DNLI Stock Holding History

NBC Securities’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.1K Sell
938
-6,679
-88% -$137K ﹤0.01% 1575
2026
Q1 		$146K Buy
7,617
+1,081
+17% +$21.5K 0.01% 952
2025
Q4 		$108K Buy
6,536
+6,004
+1,129% +$101K 0.01% 1050
2025
Q3 		$7.72K Hold
532
– – ﹤0.01% 2079
2025
Q2 		$7K Hold
532
– – ﹤0.01% 2028
2025
Q1 		$7K Buy
+532
New +$10.2K ﹤0.01% 1799
2024
Q4 		– Sell
-532
Closed -$15K – 1463
2024
Q3 		$15K Hold
532
– – ﹤0.01% 1605
2024
Q2 		$12K Buy
532
+197
+59% +$3.78K ﹤0.01% 1614
2024
Q1 		$6K Hold
335
– – ﹤0.01% 1815
2023
Q4 		$7K Hold
335
– – ﹤0.01% 1793
2023
Q3 		$6K Buy
+335
New +$8.5K ﹤0.01% 1825

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NBC Securities's DNLI Position: Q2 2026 in Review

NBC Securities reduced its Denali Therapeutics (DNLI) stake by 88% in Q2 2026, selling an estimated $137K and leaving 938 shares worth $24.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1575.

NBC Securities first reported a position in DNLI in Q3 2023 and has held it in 11 quarters since. The position peaked at $146K in Q1 2026. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • NBC Securities held 938 shares of Denali Therapeutics worth $24.1K as of Q2 2026.
  • NBC Securities sold 6,679 Denali Therapeutics shares in Q2 2026, an estimated $137K.
  • Denali Therapeutics made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1575 holding.
  • NBC Securities first reported a position in Denali Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Denali Therapeutics position peaked at $146K in Q1 2026.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.